180 Life Sciences Corp. (NASDAQ: ATNF)
$2.08
-0.0500 ( -2.35% ) 128.5K
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
Market Data
Open
$2.08
Previous close
$2.13
Volume
128.5K
Market cap
$1.91M
Day range
$2.00 - $2.28
52 week range
$1.31 - $21.28
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| pre | Proxies and info statements | 7 | Dec 14, 2023 |
| 8-k | 8K-related | 14 | Dec 04, 2023 |
| 8-k | 8K-related | 16 | Nov 29, 2023 |
| 8-k | 8K-related | 14 | Nov 28, 2023 |
| 8-k | 8K-related | 13 | Nov 16, 2023 |
| 10-q | Quarterly Reports | 61 | Nov 09, 2023 |
| 8-k | 8K-related | 13 | Oct 18, 2023 |
| 8-k | 8K-related | 13 | Oct 13, 2023 |
| 8-k | 8K-related | 17 | Sep 28, 2023 |
| 8-k | 8K-related | 13 | Sep 22, 2023 |